SCHEMBL21660444

SCHEMBL21660444

CCN(C)C(C)CN1c2ccccc2Sc2ccccc21

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 7/20 0.75
▸ CHRM2 P08172 6/20 0.75
▸ HTR1A P08908 6/20 0.75
▸ CHRM1 P11229 6/20 0.75
▸ ADRA1A P35348 6/20 0.75
▸ OPRM1 P35372 6/20 0.75
▸ DRD3 P35462 6/20 0.75
▸ KCNH2 Q12809 6/20 0.75
▸ ADRA2A P08913 5/20 0.75
▸ DRD1 P21728 5/20 0.75
▸ ALDH1A1 P00352 4/20 0.75
▸ SLC6A2 P23975 4/20 0.75
▸ SLC6A4 P31645 4/20 0.75
▸ CYP1A2 P05177 4/20 0.75
▸ ALOX15 P16050 3/20 0.75
▸ HSD17B10 Q99714 3/20 0.75
▸ SLC22A1 O15245 3/20 0.75
▸ HIF1A Q16665 3/20 0.75
▸ BCHE P06276 3/20 0.75
▸ KDM4E B2RXH2 3/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethopropazine SCHEMBL34046 0.86 CYP2D6 (1.00) CYP2D6CHRM2HTR1ACHRM1ADRA1A
Ethopropazine SCHEMBL29426328 0.86 CYP2D6 (1.00) CYP2D6CHRM2HTR1ACHRM1ADRA1A
Ethopropazine SCHEMBL34045 0.86 CYP2D6 (1.00) CYP2D6CHRM2HTR1ACHRM1ADRA1A
(S)-Promethazine SCHEMBL2900853 0.85 CYP2D6 (1.00) CYP2D6CHRM2HTR1ACHRM1ADRA1A
Promethazine SCHEMBL26777 0.85 CYP2D6 (1.00) CYP2D6CHRM2HTR1ACHRM1ADRA1A
Promethazine SCHEMBL29372077 0.85 CYP2D6 (1.00) CYP2D6CHRM2HTR1ACHRM1ADRA1A
Promethazine SCHEMBL4700 0.85 CYP2D6 (1.00) CYP2D6CHRM2HTR1ACHRM1ADRA1A
Ethopropazine SCHEMBL30516992 0.84 ALDH1A1 (1.00) CYP2D6CHRM2HTR1ACHRM1ADRA1A
Ethopropazine SCHEMBL123703 0.84 ALDH1A1 (1.00) CYP2D6CHRM2HTR1ACHRM1ADRA1A
Ethopropazine SCHEMBL123702 0.84 ALDH1A1 (1.00) CYP2D6CHRM2HTR1ACHRM1ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10869933-B2 Oligomer-phenothiazine conjugates NEKTAR THERAPEUTICS (US) 2020-12-22 — — US disclosed
US-20200038517-A1 OLIGOMER-PHENOTHIAZINE CONJUGATES NEKTAR THERAPEUTICS (US) 2020-02-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10869933-B2 Oligomer-phenothiazine conjugates HTT, MAPT, SLCO1B3 CYP2D6 283/4885CHRM2 973/4885HTR1A 518/4885
US-20200038517-A1 OLIGOMER-PHENOTHIAZINE CONJUGATES HTT, MAPT, SLCO1B3 CYP2D6 283/4885CHRM2 973/4885HTR1A 518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback